FUSION FPX-01-01
10 Dec 2020
FPX-01-01
NCT03746431
A Phase 1 Study of [225Ac]-FPI-1434 Injection in Patients With Advanced Solid Tumours
Fusion Pharmaceuticals
Cancer Type | All cancers |
---|---|
Trial Type | Treatment |
Phase | Phase I |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | Advanced Solid Tumors |
Cancer Stage | Locally Recurrent or Locally Advanced |
Anticipated Start Date | 2019-01-17 |
Anticipated End Date | 2021-01-31 |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Professor Michael Brown |
Recruitment Status | Recruiting |